Scarica l'app Stockscreener
0.4626
3.73%
-0.0178
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ABVC Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.4804
Aprire:
$0.5
Volume 24 ore:
89,498
Relative Volume:
0.45
Capitalizzazione di mercato:
$11.72M
Reddito:
$152.40K
Utile/perdita netta:
$-10.52M
Rapporto P/E:
-0.1856
EPS:
-2.4931
Flusso di cassa netto:
$-4.26M
1 W Prestazione:
-11.23%
1M Prestazione:
-29.44%
6M Prestazione:
-33.30%
1 anno Prestazione:
-66.96%
Intervallo 1D:
$0.461
$0.507
Intervallo di 1 settimana:
$0.46
$0.55
Portata 52W:
$0.4053
$1.73
Abvc Biopharma Inc Stock (ABVC) Company Profile
Nome
Abvc Biopharma Inc
Settore
Industria
Telefono
510-668-0881
Indirizzo
44370 OLD WARM SPRINGS BLVD., FREMONT
Confronta ABVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
0.4625 | 11.72M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.36 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
719.25 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
670.87 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.48 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.28 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Abvc Biopharma Inc Borsa (ABVC) Ultime notizie
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest - Defense World
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 42.6% in December - Defense World
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market - Yahoo Finance
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees - Yahoo Finance
Head to Head Review: ABVC BioPharma (NASDAQ:ABVC) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement - Yahoo Finance
ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products - Yahoo Finance
ABVC BioPharma Expands Global Patent Portfolio for ADHD Treatment - Citybuzz
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market - Yahoo Finance
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21 - The Manila Times
ABVC BioPharma Seeks to Revolutionize Mental Health - GlobeNewswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 24.2% in November - Defense World
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners - The Manila Times
ABVC BioPharma Secures $200,000 in First Cash Licensing - GlobeNewswire
ABVC BioPharma Secures Major Oncology Licensing Deal: $200K Initial Payment, Up to $50M in Future Royalties - StockTitan
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 79.2% - Defense World
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World
ABVC BioPharma Inc. (ABVC) Quarterly 10-Q Report - Quartzy
ABVCABVC BioPharma, Inc. Latest Stock News & Market Updates - StockTitan
ABVC BioPharma Reports First Operational Profit in Q3 2024, Showcasing Significant Financial Improvement - Citybuzz
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones - The Manila Times
ABVC BioPharma Reports First-Ever Operational Profit, 2,352% Revenue Surge in Q3 | ABVC Stock News - StockTitan
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest - Defense World
ABVC BioPharma Enters into Agreement to Exercise Warrants at Reduced Price - Defense World
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
ABVC BioPharma secures additional licensing fees - Investing.com
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - The Manila Times
ABVC BioPharma secures additional licensing fees By Investing.com - Investing.com UK
ABVC BioPharma Receives $50,000 in Incremental Licensing - GlobeNewswire
ABVC BioPharma switches to new independent accounting firm - Investing.com
ABVC BioPharma switches to new independent accounting firm By Investing.com - Investing.com UK
ABVC BioPharma Inc (ABVC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World
1832 Asset Management L.P. Has $21.08 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Avidity Biosciences initiated with a Buy at Goldman Sachs - TipRanks
ABB unveils number of investors with maximum and minimum stakes in shares - Trend News Agency
ABB (NYSE:ABBNY) Stock Price Passes Above 200 Day Moving Average of $52.74 - MarketBeat
Rhumbline Advisers Sells 495,177 Shares of Ambev S.A. (NYSE:ABEV) - Defense World
Abans Holdings shares: Aditya Birla Money estimates small-cap stock to give multibagger returns. Buy or avoid? | Stock Market News - Mint
ABB (NYSE:ABBNY) Shares Cross Above 200 Day Moving Average of $52.74 - Defense World
Abbott Laboratories (NYSE:ABT) Shares Up 0.3% - MarketBeat
Bank of Montreal Can Trims Stock Holdings in Abbott Laboratories (NYSE:ABT) - Defense World
J. Stern & Co. LLP Has $30.67 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abbott Laboratories (NYSE:ABT) Shares Acquired by Frank Rimerman Advisors LLC - Defense World
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Xponance Inc. Has $24.89 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abans Holdings Limited gets buy call with target price of Rs 710 | Check details here - India.com
Asset Management Firm Abans Holdings Gets Buy Rating from Aditya Birla MoneyKnow Share Price Target - Times Now
Abvc Biopharma Inc Azioni (ABVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):